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Abstract
Background: Non-dipping pattern in hypertensive patients has been shown to be associated with
an excess of target organ damage and with an adverse outcome. The aim of our study was to assess
whether a reduced nocturnal fall in blood pressure (BP), established on the basis of a single 24-h
BP monitoring, in treated essential hypertensives is related to more prominent cardiac alterations.
Methods: We enrrolled 229 treated hypertensive patients attending the out-patient clinic of our
hypertension centre; each patient was subjected to the following procedures : 1) clinic BP
measurement; 2) blood and urine sampling for routine blood chemistry and urine examination; 3)
standard 12-lead electrocardiogram; 4) echocardiography; 5) ambulatory BP monitoring (ABPM).
For the purpose of this study ABPM was carried-out in three subgroups with different clinic BP
profile : 1) patients with satisfactory BP control (BP < 140/90 mmHg; group I, n = 58); 2) patients
with uncontrolled clinic BP (clinic BP values ≥ 140 and/or 90 mmHg) but lower self-measured BP
(< 20 mmHg for systolic BP and/or 10 mmHg for diastolic BP; group II, n = 72); 3) patients with
refractory hypertension, selected according to WHO/ISH guidelines definition (group III, n = 99).
Left ventricular hypertrophy (LVH) was defined by two gender-specific criteria (LV mass index
≥125/ m2 in men and 110 g/m2 in women, ≥51/gm2.7 in men and 47/g/m2.7 in women).
Results: Of the 229 study participants 119 (51.9%) showed a fall in SBP/DBP < 10% during the
night (non-dippers). The prevalence of non-dippers was significantly lower in group I (44.8%) and
II (41.6%) than in group III (63.9%, p < 0.01 III vs II and I). The prevalence of LVH varied from 10.3
to 24.1% in group I, 31.9 to 43.1% in group II and from 60.6 to 67.7% in group III (p < 0.01, III vs II
and I). No differences in cardiac structure, analysed as continuous variable as well as prevalence of
LVH, were found in relationship to dipping or non-dipping status in the three groups.
Conclusions:  In treated essential hypertensives with or without BP control the extent of
nocturnal BP decrease is not associated with an increase in LV mass or LVH prevalence; therefore,
the non-dipping profile, diagnosed on the basis of a single ABPM, does not identify hypertensive
patients with greater cardiac damage.
Published: 14 February 2003
Cardiovascular Ultrasound 2003, 1:1
Received: 27 January 2003
Accepted: 14 February 2003
This article is available from: http://www.cardiovascularultrasound.com/content/1/1/1
© 2003 Cuspidi et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all 
media for any purpose, provided this notice is preserved along with the article's original URL.Cardiovascular Ultrasound 2003, 1 http://www.cardiovascularultrasound.com/content/1/1/1
Page 2 of 9
(page number not for citation purposes)
Background
Left ventricular hypertrophy (LVH) established either by
electrocardiography or echocardiography is an important
predictor of cardiovascular morbidity and mortality in the
general population, in hypertensive patients and in pa-
tients with coronary artery disease [1–4]. Although LVH in
hypertensive patients is an adaptive response to increased
left ventricular wall stress, the development of myocardial
hypertrophy is dependent on several hemodynamic and
humoral factors. Duration and severity of hypertension,
diurnal variations of blood pressure (BP), and 24 hour
overall BP variability are the most important hemody-
namic variables involved in the pathogenesis of LVH
[5,6]. The advent and the large diffusion of non-invasive
techniques for measuring ambulatory BP have made it
possible to monitor BP throughout the day. The prevalent
circadian pattern in both normotensive and hypertensive
individuals is characterized by a marked decrease of systo-
lic and diastolic BP during the night (dippers), but there is
a noticeable fraction of subjects who exhibit a diminished
nocturnal decline in BP (non-dippers) [7,8]. Many clinical
studies with non-invasive ambulatory BP monitoring
(ABPM) have shown that some cardiovascular complica-
tions of arterial hypertension and namely LVH, tend to be
more frequent in patients in whom BP does not fall, or
falls scarcely at night and consequently, suffer a prolonged
exposure to high BP lever over the 24 hour [9–11]. More-
over, three prospective studies conducted in patients with
hypertension [12–14] and one population-based longitu-
dinal survey confirmed that a reduced nocturnal decline
in BP is a predictor of cardiovascular events [15]. Howev-
er, the clinical significance of the non-dipping pattern has
not gone undisputed. Some recent studies have not
shown substantial differences between the extent of cardi-
ovascular preclinical alterations among untreated hyper-
tensive dippers and non-dippers with similar BP load
throughout the 24 hour period [16,17]. Furthermore, it
has been demonstrated that the classification of hyperten-
sive patients into dippers and non-dippers based on single
ABPM has a poor reproducibility over time, both in the
absence and the presence of treatment [18,19].
In this study we have evaluated, in a large group of treated
essential hypertensive patients, with different clinic BP
patterns, whether the extent of nocturnal fall in BP, as-




The present analysis involved 229 patients with treated es-
sential hypertension attending the out-patient clinic of
our hypertension centre during a period of nine months
(2 january – 30 september 2001). One hundred twenty
five out of 229 patients had been referred to our centre for
the first time by their general practitioners because of in-
adequate BP control or in order to exclude secondary
forms of hypertension and the remaining 104 patients
had been regularly followed-up (one or two times/year,
mean 1.3) for a period of at least six months (range 6–
122). Three subgroups of subjects with different clinic BP
profile were selected for the aim of this study : 1) patients
with satisfactory clinic BP control (clinic BP values < 140/
90 mmHg) (group I, n = 58); 2) patients with uncon-
trolled clinic BP (clinic BP values ≥ 140 and/or ≥ 90 mm-
Hg) but lower self-measured BP (< 10 mmHg for diastolic
BP and/or < 20 mmHg for systolic BP; group II, n = 72);
3) patients with refractory hypertension (persistent clinic
BP values of 140/90 mmHg or above, or as persisting
systolic BP values of 140 mmHg or above in the case of
isolated systolic hypertension, despite the assumption of
three or more antihypertensive drugs in adequate doses in
the past three months) (group III, n = 99) [20]. After in-
formed consent had been obtained during the initial or
follow-up visit all patients were subjected to the following
procedures within 1–3 weeks : 1) clinic BP measurement ;
2) blood and urine sampling for routine blood chemistry
and urine examination; 3) standard 12-lead electrocardi-
ogram; 4) echocardiogram; 5) ambulatory BP monitor-
ing. In all subjects special laboratory studies for secondary
causes of hypertension were performed when considered
appropriate on clinical grounds. Patients with secondary
hypertension, congestive heart failure, previuos myocar-
dial infarction, cardiac valve diseases, history of coronary
artery by-pass, poor echocardiographic window, condi-
tions preventing technically adequate ABPM (e.g. atrial fi-
brillation and other major dysrhythmias) and major non-
cardiovascular disease were excluded. Compliance to
treatment was evaluated systematically during patient's
visits by structured questions on the regularity of drug
consumption.
Clinic blood pressure measurement
BP was measured in the hospital out-patient clinic by a
physician with a mercury sphygmomanometer (first and
fifth phases of Koroktoff sounds taken as SBP and DBP re-
spectively) after the subjects had rested for 5–10 min in
the sitting position. Three measurements were taken at 1
min intervals, and the average was used to define clinic
systolic and diastolic BP.
Ambulatory blood pressure monitoring
Twenty-four-hour ABPM was carried out on the non-dom-
inant arm using a Spacelabs 90207 device (Spacelabs Inc.,
Richmond, Washington, USA) after validation of readings
against a mercury sphygmomanometer by means of a Y
tube. The device was set to obtain BP readings at 15 min
intervals during the day (0700–2300 h) and at 20 min in-
tervals during the night (2300–0700 h). The time of appli-
cation (± 1 h) and the type of device were the same in allCardiovascular Ultrasound 2003, 1 http://www.cardiovascularultrasound.com/content/1/1/1
Page 3 of 9
(page number not for citation purposes)
patients. The patients were instructed to attend their usual
day-to-day activities but to keep still at the times of meas-
urements ; all subjects were asked to go to bed not later
than 2300 h and to stay in bed until 0700. The BP moni-
toring was always performed over a working day (Monday
to Friday). Each ABPM dataset was first automatically
scanned to remove artefactual readings, according to
preselected editing criteria. Systolic readings > 260 or < 70
mmHg and diastolic readings > 150 or < 40 mmHg were
automatically discarded. The recording was then analysed
to obtain 24 h, daytime and night-time average SBP, DBP
and heart rates. Nocturnal dipping was defined as a reduc-
tion in average SBP and DBP at night greater than 10%
compared with average daytime values [10].
Echocardiography
M-mode, two-dimensional and Doppler echocardio-
graphic examinations were performed with subjects in the
partial left decubitus position using commercially availa-
ble instruments (ATL HDI 3000 and 5000, Bothell, Wash-
ington, USA) equipped with 2.25 or 2.5 MHz imaging
transducers. End-diastolic and end-systolic left ventricular
internal diameter (LVIDd, LVIDs), interventricular sep-
tum thickness (IVST) and posterior wall thickness (PWT)
were calculated from two-dimensionally guided M-mode
tracing and measured during five consecutive cycles ac-
cording to the Penn convention [21]. Left ventricular mass
was estimated by Devereux's formula and normalized by
body surface area or height 2.7 [22,23]. Relative wall thick-
ness (RWT) was calculated as (2xPWT/LVIDd). LVH was
defined following two different criteria, i.e. when left ven-
tricular mass index (LVMI) was equal or exceeded 125 g/
m2 in men and 110 g/m2 in women (24), and 51 g/m2.7
in men and 47 g/m2.7 in women [25]. Patterns of left ven-
tricular geometry were defined according to Ganau et al.
[26] : 1) LV concentric remodelling, when a normal LVMI
was combined with RWT ≥ 0.45; 2) concentric LVH, when
left ventricular hypertrophy occurred with a RWT ≥ 0.45;
3) eccentric LVH, when increased LV mass was associated
with RWT < 0.45. Left ventricular systolic function was as-
sessed by endocardial fractional shortening. Left ventricu-
lar filling was assessed by recording mitral flow by
standard pulsed Doppler technique, and the following pa-
rameters were considered : early diastolic peak flow veloc-
ity (E), late diastolic peak flow velocity (A) and the ratio
of the early to late flow velocity peaks (E/A ratio).
Statistical analysis
Values have been expressed as means ± SD or as percent-
ages. Differences between groups were assessed by analy-
sis of variance (ANOVA) with the Scheffe post-hoc test.
Mean values for dipper and non-dipper patients were
compared using Student's t-test for independent samples.
Chi-square statistics were used to compare categorical var-
iables between groups. Correlations were obtained by us-
ing Pearson's equation. The limit of statistical significance
was set at P < 0.05. Data management and statistical anal-
Table 1: Clinical and laboratory characteristics of study population
I (n = 58) II (n = 72) III (n = 99) P
Age (years) 54.1 ± 8.5 56.1 ± 10.1 56.6 ± 12.2 NS
Gender (M/F) 32/26 47/25 47/52 NS
Body mass index (kg/m2) 25.6 ± 3.2 26.1 ± 3.1 28.4 ± 5.1 p <0.01*
Duration of HT (years) 6.9 ± 5.1 6.3 ± 4.9 7.1 ± 5.0 NS
Current smokers (%) 25.9 24.2 26.5 NS
Heart rate (b/min) 72.3 ± 8.1 72.5 ± 12.1 69.9 ± 10.1 NS
Clinic BP:
SBP (mmHg) 128.4 ± 13.2 157.9 ± 14.9 164.4 ± 23.0 p < 0.01*
DBP (mmHg) 81.1 ± 7.0 97.4 ± 8.4 98.3 ± 11.3 p < 0.01§
Ambulatory BP
24-h SBP(mmHg) 125.3 ± 8.6 131.1 ± 11.3 144.1 ± 16.8 p < 0.01*
24-h DBP(mmHg) 80.0 ± 6.0 80.6 ± 8.3 85.6 ± 11.8 p < 0.01*
Daytime SBP(mmHg) 129.0 ± 9.6 136.3 ± 11.6 147.3 ± 17.9 p < 0.01*
Daytime DBP(mmHg) 83.5 ± 6.8 85.4 ± 8.6 89.8 ± 11.5 p < 0.05 *
Nighttime SBP (mmHg) 115 ± 8.8 120.7 ± 12.9 135.5 ± 18.7 p < 0.01*
Nighttime DBP (mmHg) 70.8 ± 6.1 71.5 ± 9.3 77.8 ± 10.6 p < 0.01*
Blood glucose(mmol/l) 5.17 ± 0.67 5.44 ± 0.96 5.80 ± 1.72 p < 0.05§
T serum cholesterol 
(mmol/l)
5.73 ± 0.93 5.84 ± 0.96 5.71 ± 1.07 NS
Serum creatinine(µmol/l) 88.1 ± 16.2 89.2 ± 15.6 88.2 ± 22.6 NS
Data are means ± SD; NS = not significant; HT = hypertension; SBP = systolic blood pressure ; DBP = diastolic blood pressure * III vs II, I ; §III vs I ;Cardiovascular Ultrasound 2003, 1 http://www.cardiovascularultrasound.com/content/1/1/1
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ysis were performed using Statwiev SAS Version 4.5 Soft-
ware (Abacus Concepts Inc, Berkeley, USA).
Results
Demographic, clinical and laboratory characteristics of
the study population are reported in Table 1. Mean age,
heart rate, known duration of hypertension, smoking
habit, creatinine, total serum cholesterol did not differ sig-
nificantly between the groups. Body mass index, clinic
SBP and ambulatory SBP/DBP were significantly higher in
patients with refractory hypertension than in other two
groups. Serum glucose and DBP were significantly greater
in group III than in group I. Pharmacological treatment
regimens were substantially different in the three groups
(Table 2). 55% of the patients in group I, and 52% in
group II were receiving only morning antihypertensive
medication ;whereas in almost all refractory hypertensives
drugs were administered both at morning and at evening.
The compliance with pharmacological treatment was sat-
isfactory in all groups: all patients reported taking the pre-
scribed drugs regularly.
Of the 229 study participants 110 showed a fall in SBP/
DBP > 10% during nighttime sleep and were categorized
as dippers, while the remaining 119 showed a fall ≤ 10%
and were categorized as non-dippers. The prevalence rates
of non-dippers were significantly lower in group I
(44.8%) and II (41.6%) than in group III (63.9%, p <
0.01).
Depending on the method of LV mass indexation and the
criteria used, LVH was present in a percentage ranging
from 10.3% to 24.1% in group I, 31.9% to 43.1% in
group II and from 60.6% to 67.7% in group III. In all three
groups a lower prevalence was found using the gender
specific partition value indexed by body surface area (125/
110 g/m2). Regardless of the criteria used for the diagnosis
eccentric hypertrophy was the most common type of LVH
in both group I and II, whereas concentric hypertrophy
was the most frequent one in group III.
BP nocturnal profile and cardiac structure and function
Clinical and laboratory characteristics of all three groups
according to classification into dippers and non dippers
are reported in Table 3, 4 and 5. Left ventricular diastolic
and systolic diameter, LV absolute wall ticknessess, as well
relative wall thickness, LV mass and LV mass indexed both
for body surface area and height 2.7, endocardial fraction-
al shortening and early/late mitral flow velocity ratio were
similar in dippers and nondippers. Moreover, when the
echocardiographic data were analysed in a categorical way
as presence of absence of cardiac hypertrophy, the preva-
lence of LVH was similar in all three groups of dippers and
nondippers (Fig. 1).
Correlations between LV mass and BP
LVMI did not significantly correlate with any measure of
clinic BP or ABP in both group I and II. In contrast in re-
fractory hypertensives (group III) a significant correlation
was found only between LVMI and systolic and diastolic
daytime BP (r= 0.21, p < 0.03 and r = 0.22, p < 0.02); in
fact, the strengths of association of LVMI with nighttime
BP or 24 hour BP did not attain a statistical significance.
Discussion
The present study carried out in a large sample of treated
dipper and non-dipper essential hypertensive patients
with different clinic BP control and prevalence of LVH
shows that a reduced nocturnal fall in BP, established on
the basis of a single ABPM, is not associated with more
pronounced cardiac involvement. In fact, we found no
difference in left ventricular size, systolic and diastolic
Table 2: Anti-hypertensive medications of study population
Group I Group II Group III P
Diuretics 52 % 42% 78% p < 0.01*
ACE inhibitors and Angi-
otensin II antagonists
65% 66% 86% p < 0.01*
Calcium Antagonists 41% 47% 67% p < 0.05*
Beta-blockers 29% 41% 57% p < 0.05*
Alpha-blockers 3% 7% 31% p < 0.05*
Treatment regimens
Group I Group II Group III P
Monotherapy 28% 37% 0% p < 0.01*
Two drugs 55% 30% 0% p < 0.01*
Three drugs 14% 21% 51% p < 0.01*
Four or more drugs 3% 12% 49% p < 0.01*
* III vs II and ICardiovascular Ultrasound 2003, 1 http://www.cardiovascularultrasound.com/content/1/1/1
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function or prevalence of cardiac hypertrophy between
patients with and without a normal fall in BP during
nighttime. This lack of difference in cardiac involvement
was found when all three subgroups of dippers and non-
dippers were considered, at any level of BP control
achieved during chronic antihypertensive therapy. This
evidence can be discussed as follows: first, not only the de-
mographic and metabolic characteristics, but also clinic
BP and mean 24-h BP values were superimposable in dip-
pers and non-dippers, allowing a comparison between
homogenous groups of treated hypertensives that differ
only by the extent of nocturnal dip. Therefore, overall 24-
h BP load rather than the day-night difference in BP seems
to play a pivotal role in the maintenance or regression of
LVH in chronically treated hypertensives. It has already
been noted that the greater left ventricular mass reported
in some studies in non-dippers may not be related to the
non-dipping phenomenon per se, but to a greater BP level
over 24-h [27]; this may be also true for other signs of tar-
get organ damage such as carotid structural alterations
[28]. The association between non-dipping and target or-
gan damage, however, remains somewhat controversial.
Our data are in agreement with several studies who failed
to detect any significant difference between dipper and
non-dipper hypertensive patients or found only a very
mild impact of a blunted nocturnal BP reduction on car-
diovascular characteristics [17,29–31]. In particular,
Ferrrara et al. assessing LV structure and diastolic function
as well carotid artery morphology in 123 patients with
long-standing hypertension in whom antihypertensive
treatment was discontinued for a period of 4 weeks, dem-
onstrated any significant difference in LV and carotid
Figure 1
Prevalence of left ventricular hypertrophy (LVH) according two echocardiographic diagnostic criteria in dipper and non-dipper 
treated hypertensive patients, with different clinic blood pressure profiles : group I (satisfactory clinic BP control), group II 
(uncontrolled clinic BP, but lower self-measured BP), group III (refractory hypertension).Cardiovascular Ultrasound 2003, 1 http://www.cardiovascularultrasound.com/content/1/1/1
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structure among dippers and non-dippers, suggesting that
unfavorable consequences of non dipper status might be
blunted by the duration of hypertension [32]. Second,
only in patients with refractory hypertension a significant
association between BP levels under treatment and left
ventricular mass was found; however, the strengths of
these correlations attained a statistical significance for
systolic and diastolic daytime BPs but not for nighttime
BPs, suggesting a limited effect of nocturnal BP profile, as-
sessed by a single ABPM, on cardiovascular remodelling in
this particularly selected group of treated hypertensives.
Our results, however, do not demonstrate that the noctur-
nal BP behavior is not determinant in the development
and progression of cardiac structural alterations, but that
it is probably not relevant when the nighttime fall in BP
has been evaluated on the basis of a single ABPM. The
classification of hypertensive patients into dippers and
non-dippers has a low reproducibility over time [33,34].
This limited reproducibility is presumably related to the
fact that the quality and depth of sleep as well the mental
and physical activity during daytime can easily vary from
one recording session to another. Omboni et al have
shown that about 40% of hypertensive patients included
in the Study on Ambulatory Monitoring of Pressure and
Lisinopril Evaluation (SAMPLE) classified into dippers
and non-dippers changed status when they were studied
again after 1 year [19]. Furthermore, the regression of LVH
by antihypertensive treatment was significantly due to the
therapy-induced decrease in mean 24-h, daytime and
nigthttime BP but not to the effect of the day-night differ-
ence in BP [35]. Manning et al examined the long-term
variability in nocturnal BP pattern and showed that 56%
of their subjects did not change the dipping status whereas
the remaining 44% had a variable pattern [36]. More re-
cently, ourselves found a different short-term variability
in circadian BP according to dipping status at baseline, be-
ing significantly greater in patients classified at first ABPM
as non-dippers (28%) than in dippers (9%) [36]. Accord-
ingly to these findings the assumption that one single 24-
h recording can characterize an individual's habitual noc-
turnal BP profile needs to be reconsidered. The increasing
evidence for the linited reproducibility of circadian varia-
tion in BP suggests that in a noticeable proportion of pa-
tients the non-dipping pattern cannot be considered as a
definite clinical trait. Thirdly, the reduced nocturnal fall in
BP was found in the majority of the whole study popula-
tion (53%), and appeared particularly high in the group
of refractory hypertensives (67%) confirming earlier re-
Table 3: Clinical characteristics of patients with satisfactory BP control (group I), according to dipping status.
Dippers (n = 32) Non-dippers (n = 26) P
Age (years) 54.7 ± 8.6 53.4 ± 8.5 NS
Gender (M/F) 17/15 15/11 NS
Body mass index (kg/m2) 25.2 ± 3.3 26.3 ± 3.2 NS
Duration of HT (years) 6.8 ± 5.6 6.9 ± 5.7 NS
Current smokers (%) 22 30 NS
Heart rate (b/min) 72.1 ± 8.1 74.1 ± 7.5 NS
Clinic BP
SBP (mmHg) 123.1 ± 9.3 121.5 ± 10.3 NS
DBP (mmHg) 78.6 ± 7.0 77.6 ± 5.7 NS
Ambulatory BP
24-h SBP (mmHg) 127.1 ± 9.7 123.2 ± 6.7 NS
24-h DBP (mmHg) 81.1 ± 6.4 78.7 ± 5.5 NS
Daytime SBP (mmHg) 132.4 ± 10.5 124.9 ± 6.7 p < 0.01
Daytime DBP (mmHg) 85.0 ± 6.9 81.0 ± 5.8 p < 0.05
Nighttime SBP (mmHg) 112.8 ± 8.9 118.4 ± 7.7 p < 0.05
Nighttime DBP (mmHg) 69.3 ± 5.9 72.6 ± 6.0 p < 0.05
Blood glucose (mmol/l) 5.15 ± 0.77 5.14 ± 0.49 NS
T serum cholesterol (mmol/l) 5.70 ± 1.01 5.83 ± 0.85 NS
Serum creatinine (µmol/l) 91.3 ± 15.9 86.2 ± 16.5 NS
LVM (g) 171.9 ± 44.0 179.2 ± 37.1 NS
LVMI (g/m2) 97.0 ± 19.4 98.5 ± 15.9 NS
LVMI (g/m2.7) 43.1 ± 8.2 44.6 ± 7.7 NS
RWT 0.40 ± 0.04 0.39 ± 0.07 NS
SF (%) 39.1 ± 5.9 38.7 ± 6.1 NS
E/A 1.3 ± 0.3 1.3 ± 0.4 NS
LVMI = left ventricular mass index; RWT = relative wall thickness; SF = shortening fraction; E/A = early diastolic peak flow velocity (E)/late diastolic 
peak flow velocity (A). *III vs II e ICardiovascular Ultrasound 2003, 1 http://www.cardiovascularultrasound.com/content/1/1/1
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ports of an increased prevalence of non-dippers among
patients receiving antihypertensive therapy compared to
untreated patients with recently diagnosed hypertension
[38,39]. Different factors may explain this finding : 1) in
treated hypertensive patients non-dipping could be asso-
ciated with the lack of therapeutical coverage for the 24 h
of the day; this should be true for group I and II in whom
the percentage of patients who were receiving only morn-
ing medication was significantly greater among non-dip-
pers as compared with dippers, but probably not for
refractory hypertensives (group III), who were taking three
or more drugs (scheduled both at morning and at
evening); 2) the mechanism(s) involved in the lack of
nocturnal dip remains unclear; this complex phenome-
non may reflect a predominance of pressure influences
(i.e. angiotensin II, chatecolamines etc) over depressor
ones (i.e. reduction of sympathetic nerve activity, an in-
crease in vagal activity etc) that help to regulate BP at
night, and may also result from structural vascular altera-
tions interfering with resistence vessel dilation [40]. In
this context, refractory hypertension may be considered a
clinical conditions with a large prevalence of cardiovascu-
lar structural alterations [41] potentially responsible for
the reduced nocturnal hypotension. However, despite the
very high prevalence rates of LVH and non-dipping profile
found in our group of refractory hypertensives we failed to
demonstrate any difference in cardiac structural and func-
tional abnormalities among dipper and non dipper
patients.
Conclusions
The present study performed in treated hypertensive pa-
tients with different clinic BP control profiles indicates
that the lack of nocturnal decline in BP is not associated
with a more pronounced cardiac involvement; these re-
sults strengthen the doubts about its clinical significance
as an independent risk factor in non-dipper patients clas-
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